Lindahl acted as legal advisor to Corline Biomedical

Through the agreement, Imperative Care is given the exclusive right to use CHS™ in all types of neurovascular products given a certain level of compensation. Corline undertakes to supply CHS™-coated products according to defined specifications, but also to assist in further development and market registration of the current product. In addition, Corline will participate in the development of additional CHS™-coated products within the indication area. These products have the potential to generate revenue for Corline of approximately SEK 150 million per year and a total of more than SEK 1 billion.
Lindahl's team consisted of Hugo Norlén and Erika Svensson.
Corline's press release (in Swedish) is available here.
Do you want to know more? Contact:
Hugo Norlén
Partner | AdvokatErika Svensson
Partner | AdvokatCarousel items
-
Cases and transactions
7/4/2025
Lindahl advises Lyten on acquisition of Northvolt’s energy storage business
Silicon Valley based Lyten has acquired Northvolt's battery storage business in Gdansk – Europe's largest manufacturing facility for battery energy storage systems. Lindahl acted as legal advisor to Lyten in the transaction.
-
Knowledge
7/4/2025
Gambling addict found in favour of gambling company - Supreme Court applies Section 33 of the Contracts Act
On 1 July 2025, the Supreme Court published the decision "Nätkasinot". A former customer (PL) had claimed that a gambling company should refund approximately SEK 5.8 million to him. In support of his claim, PL stated that the gambling company had...
-
News articles
6/27/2025
Johan Åberg appointed new Managing Partner at Lindahl in Stockholm
As of July 1, Advokatfirman Lindahl’s Stockholm office has a new Managing Partner. Johan Åberg succeeds Monica Lagercrantz, who has led the Stockholm office since January 2022.
-
Portraits
6/23/2025
20 years at Lindahl: "It's a good grade, you develop all the time"
Johan Tollgerdt Ronnell has been part of Lindahl for almost 20 years. "It's a good mark, there have always been good and new career and development opportunities here."
-
Read more news and insights?